Big pharma heats up with high performance for drugs, earnings


The pharmaceutical sector was on fire Monday, with successful trials, FDA approvals, and some deal action. So far, Tuesday is shaping up to be similar.

Big pharma takes its hits for questionable practices. But on days like these, we remember the enormous value and contributions that drug companies have on our lives, pushing forward with research, development, and innovation. And it's days like these that remind us why so many of us like investing in the sector.